Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation

Biology of Blood and Marrow Transplantation

Volumn 5, Issue 3, 1999, Pages 173-179

  Jabro, Gina ^a   Koc, Yener ^a   Boyle, Terry ^a   Schenkein, David P ^a   Ravalese, Joseph ^a   Wazer, David ^a   Miller, Kenneth B ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic BMT; CML; Radiation; Spleen

Indexed keywords

CREATININE;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; METHODOLOGY; RADIATION EXPOSURE; SPLEEN; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; BONE MARROW TRANSPLANTATION; CREATININE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; NEOPLASM RECURRENCE, LOCAL; SPLEEN; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032617316     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.1999.v5.pm10392963     Document Type: Article

References (44)

1. Clift RA, Storb R: Marrow transplantation for CML: the Seattle experience. Bone Marrow Transplant 17:S1, 1996.
2. Horowitz MM, Rowlings PA, Passweg JR: Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 17:S5, 1996.
3. Gluckman E, Devergie A, Bernheim A, Berger R: Splenectomy and bone marrow transplantation in chronic granulocytic leukemia. Lancet i:1392, 1983.
4. Gratwohl A, Goldman J, Gluckman E, Zwaan FE: Effect of splenectomy before bone marrow transplantation on survival in chronic granulocytic leukemia. Lancet ii:1290, 1985.
5. Thomas ED, Clift RA, Fefer A, Applebaum F, Beatty P, Bensinger W, Buckner CD: Marrow translation for the treatment of chronic myelogenous leukemia. Ann Intern Med 104:155, 1986.
6. Gratwohl A, Hermans J, Biezen A, Arcese W, de Witt T, Debusscher L, Ernest P, Ferrant A, Frassoni F, Gabrton G, Iriondo A, Kolb HJ, Link H, Niederwieser D, Ruutu T, Schmitz N, Siegert W, Torres-Gomes A, Vernant JP, Zwaan FE: No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukemia: results of a prospective randomized study. Bone Marrow Transplant 10:147, 1992.
7. Gratwohl A, Hermans J, Biezen A, Arcese W, Debusscher L, Ernest P, Ferrant A, Frassoni F, Gabrton G, Iriondo A, Kolb HJ, Link H, Niederwieser D, Ruutu T, Schmitz N, Siegert W, Torres-Gomes A, Vernant JP, Zwaan FE: Splenic irradiation before bone marrow transplantation for chronic myeloid leukemia: update of a prospective randomized study. Leuk Lymphoma 1 (Suppl. 1):221, 1993.
8. Gratwohl A, Hermans J, Biezen A, Arcese W, de Witt T, Debusscher L, Ernest P, Ferrant A, Frassoni F, Gabrton G, Iriondo A, Kolb HJ, Link H, Niederwieser D, Ruutu T, Schattenberg N, Schmitz N, Siegert W, Torres-Gomes A, Vernant JP, Zwaan FE, Apperley J: Splenic irradiation before bone marrow transplantation for chronic myeloid leukemia. Br J Haematol 95:494, 1996.
9. Speck B, Bortin MM, Champlin R, Goldman JM, Herzig RH, McGlave PB, Messner HA, Weiner RS, Rimm AA: Allogeneic bone marrow transplantation for chronic myelogenous leukemia. Lancet i:665, 1984.
10. Ferrara J, Deeg H: Graft-versus-host disease. N Engl J Med 324:667, 1991.
11. Atkinson K, Horowitz M, Gale RP, Lee MB, Rimm AA, Bortin MM: Consensus among bone marrow transplanters of chronic graft-versus-host disease. Bone Marrow Transplant 4:247, 1980.
12. Engler M: A practical approach to uniform total body irradiation. Int J Radiat Biol Phys 12:2033, 1986.
13. Miller KB, Schenkein DP, Comenzo R, Erban JK, Fpgaren T, Hirsch CA, Berkman E, Robson A: Adjusted-dose continuous infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation. Ann Hematol 68:15, 1994.
14. Sokal JE, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE, Tso CY, Braun TJ, Clarkson BD, Cervantes F, Rozman C, and the Italian Cooperative Study Group: Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood 63:789, 1984.
15. Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner CD, Greenberg P, Hansen JA, Martin P, McGuffin R, Ramberg R, Sanders JE, Singer J, Stewart P, Storb R, Sullivan K, Weiden PL, Witherspoon R: Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 204:155, 1986.
16. Biggs JC, Szer J, Crilley P, Atkinson K, Downs K, Dodds A, Concannon AJ, Avalos B, Tutschka P, Kapoor N: Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2. Blood 80:1352, 1992.
17. Wagner JE, jZaburak M, Piantoadosi S, Geller RB, Vogelsang GB, Wingard JR, Saral R, Griffin C, Shah N, Zehnbauer BA: Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits. J Clin Oncol 10:779, 1992.
18. Italian Cooperative Study Group on Chronic Myeloid Leukemia: Evaluating survival after allogeneic bone marrow transplant for chronic myeloid leukemia in chronic phase: a comparison of transplant versus no-transplant in a cohort of 258 patients first seen in Italy between 1984 and 1986. Br J Haematol 85:292, 1993.
19. Goldman JM, Szydlo R, Horowitz MH, Gale RP, Ash RC, Atkinson K, Dicke KA, Gluckman E, Herzig RH, Marmont A, Masalka T, McGlave PB, Messner H, O'Reilly RJ, Reiffers J, Rimm AA, Speck B, Veum-Stone J, Wingard JR, Zwaan FE, Bortin MM: Choice of pre-transplant treatment and timing of transplant for chronic myelogenous leukemia in chronic phase. Blood 82:2235, 1993.
20. van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu Tu, Reiffers J, Goldman JM, Apperley J, Gratwohl A: Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 20:553, 1997.
21. Dailey MO, Coleman CN, Fajardo LF: Splenic injury caused by therapeutic irradiation. Am J Surg Pathol 5:325, 1981.
22. Coleman CN, McDougall IR, Dailey MO, Ager P, Bush S, Kaplan HS: Functional hyposplenia after splenic irradiation for Hodgkin's disease. Ann Intern Med 96:44, 1982.
23. Baughan ASJ, Worsley AM, McCarthy DM, Hows JM, Catovsky D, Gordon-Smith EC, Galton DAG, Goldman JM: Haematological reconstitution and severity of graft versus host disease for chronic granulocytic leukemia: the influence of previous splenectomy. Br J Haematol 56:445, 1984.
24. Heir HE: Splenectomy and serious infections. Scand J Haematol 24:5, 1980.
25. Karup Pederson F: Postsplenectomy infections in Danish children splenectomized. Acta Paediatr Scand 72:589, 1983.
26. Ringden O, Nilddon B: Death by graft versus host disease associated with HLA mismatch, high recipient age, low marrow cell dose and splenectomy. Transplantation 40:39, 1985.
27. Kiger N, Lenfant M: Prevention of graft versus host mortality in mice by preincubation of the graft by highly purified spleen-derived immunosuppressive peptides. Transplantation 36:243, 1983.
28. Korngold R, Sprent J: Lethal graft versus host disease across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex. Immunol Rev 71:5, 1983.
29. Inoshita T, Lee CY, Tabor DC: Localized blast crisis in the spleen in a patient with chronic myelocytic leukemia. Arch Pathol Lab Med 108:609, 1984.
30. Hogan SF, Osborne BM, Butler JJ: Unexpected splenic nodules in leukemic patients. Hum Pathol 20:62, 1989.
31. Wolf DJ, Silver RT, Coleman M: Splenectomy in chronic myeloid leukemia. Ann Intern Med 89:684, 1978.
32. Deeg HJ: Acute and delayed toxicities of total body irradiation. Int J Radiat Biol Phys 9:1933, 1983.
33. Socie G, Devergie A, Girinsky T, Reiffers J, Vernant JP, Bourgeois JP, Serve P, Guyotat D, Maraninchi D, Rio B, Michallet M, Jouet JP, Milpied N, Leblond V, Pico J, Attal M, Belanger C, Gluckman E, Cosset: Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. Int J Radiat Biol Phys 20:397, 1991.
34. Tarbell N, Guinan E, Niemeyer C, Mauch P, Sallan S, Weinstein H: Late onset renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Biol Phys 15:99, 1988.
35. Lawton C, Fish B, Moulder J: Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantation. Int J Radiat Biol Phys 4:883, 1994.
36. Miralbell R, Bieri S, Mcmillod B, Helg C, Sancho G, Pastoors B, Keller A, Kurtz J, Chapuis B: Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total body irradiation and graft-versus-host disease. J Clin Oncol 14:579, 1996.
37. Latini P, Aristei C, Aversa F, Checcaglini F, Maranzano E, Panizza BM, Perrucci E, Carotti A, Martelli MF: Interstitial pneumonitis after hyperfractionated total body irradiation in HLA-matched T-depleted bone marrow transplantation. Int J Radiat Biol Phys 23:401, 1992.
38. Hartsell W, Czyzewski A, Ghalie R, Kaizer H: Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide. Int J Radiat Biol Phys 32:69, 1995.
39. Latini P, Aristei C, Aversa F, Checcaglini F, Maranzano E, Raymondi C, Panizza BM, Perrucci E, Martwlli MF: Lung damage following bone marrow transplantation after total body irradiation. Radiother Oncol 22:127, 1991.
40. Weiner R, Bortin M, Gale R, Gluckman E, Kay H, Kolb HJ, Hartz AJ, Rimm AA: Interstitial pneumonitis after bone marrow transplantation. Ann Intern Med 104:168, 1986.
41. Gore E, Lawton C, Ash R, Lipchik R: Pulmonary function changes in long term survivors of bone marrow transplantation. Int J Radiat Biol Phys 36:67, 1996.
42. Tait RC, Burnett AK, Robertson AG, McNee S, Riyami BM, Carter R, Stevenson RD: Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease. Int J Radiat Biol Phys 20: 1219, 1991.
43. Soubani AO, Miller KB, Hassoun PM: Pulmonary complications of bone marrow transplantation. Chest 109:1066, 1996.
44. Crawford SW: Supportive care in bone marrow transplantation: pulmonary complications. Cancer Treat Res 77:231, 1997.